miR-30a inhibits endothelin A receptor and chemoresistance in ovarian carcinoma

Drug resistance remains the major clinical barrier to successful treatment in epithelial ovarian carcinoma (EOC) patients, and the evidence of microRNA involvement in drug resistance has been recently emerging. Endothelin-1 (ET-1)/ET(A) receptor (ET(A)R) axis is aberrantly activated in chemoresistan...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Sestito, Rosanna, Cianfrocca, Roberta, Rosanò, Laura, Tocci, Piera, Semprucci, Elisa, Di Castro, Valeriana, Caprara, Valentina, Ferrandina, Gabriella, Sacconi, Andrea, Blandino, Giovanni, Bagnato, Anna
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2015
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4826186/
https://ncbi.nlm.nih.gov/pubmed/26675258
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.6546
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados